These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 4372920

  • 41. Clinicopathological aspects of primary hepatocellular carcinoma occurring in patients with liver cirrhosis.
    Iwamura K.
    Tokai J Exp Clin Med; 1982 Sep; 7(5):589-605. PubMed ID: 6190271
    [Abstract] [Full Text] [Related]

  • 42. Childhood cirrhosis associated with alpha-1-antitrypsin deficiency. A genetic, biochemical, and morphologic study.
    Asarian J, Archibald RW, Lieberman J.
    J Pediatr; 1975 Jun; 86(6):844-50. PubMed ID: 1079252
    [Abstract] [Full Text] [Related]

  • 43. [Role of alpha 1-antitrypsin and alpha-2 macroglobulin in hepatopathies].
    Triolo L, Mian G, Magris D, Novello E, D'Agnolo B.
    Minerva Med; 1979 Feb 18; 70(8):605-10. PubMed ID: 86175
    [Abstract] [Full Text] [Related]

  • 44. Autopsy study of liver cell carcinoma in Barcelona, Spain.
    Galindo L, Algaba F.
    Pathol Annu; 1976 Feb 18; 11():387-402. PubMed ID: 188005
    [No Abstract] [Full Text] [Related]

  • 45. Alpha-1-antitrypsin bodies in the liver.
    Blenkinsopp WK, Haffenden GP.
    J Clin Pathol; 1977 Feb 18; 30(2):132-7. PubMed ID: 191472
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Pathology of hepatocellular carcinoma.
    Mori W, Machinami R, Tanaka K.
    Pathol Res Pract; 1980 Feb 18; 169(1):4-20. PubMed ID: 6159615
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Alpha-1-antitrypsin protease inhibitor SZ phenotype and liver cirrhosis.
    Coli A, Bigotti G.
    Appl Pathol; 1989 Feb 18; 7(1):54-60. PubMed ID: 2784975
    [Abstract] [Full Text] [Related]

  • 51. [alpha 1-antitrypsin deficiency and liver diseases].
    von Schönfeld J, Breuer N.
    Dtsch Med Wochenschr; 1993 Dec 10; 118(49):1819-24. PubMed ID: 8253047
    [No Abstract] [Full Text] [Related]

  • 52. [Clinicopathologic features of hepatocellular carcinoma: an analysis of 185 cases].
    Wang YL, Du JL, Shi HY, Guo AT, Wei LX.
    Zhonghua Zhong Liu Za Zhi; 2010 Aug 10; 32(8):609-13. PubMed ID: 21122415
    [Abstract] [Full Text] [Related]

  • 53. Alpha-1-antitrypsin deficiency--liver disease.
    Nutr Rev; 1975 Jun 10; 33(6):189-90. PubMed ID: 167327
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. PIVKA-II as a Potential New Biomarker for Hepatocellular Carcinoma - A Pilot Study.
    Svobodova S, Karlikova M, Topolcan O, Pecen L, Pestova M, Kott O, Treska V, Slouka D, Kucera R.
    In Vivo; 2018 Jun 10; 32(6):1551-1554. PubMed ID: 30348715
    [Abstract] [Full Text] [Related]

  • 57. Liver cell dysplasia in alpha-1-antitrypsin deficiency.
    Cohen C, Derose PB.
    Mod Pathol; 1994 Jan 10; 7(1):31-6. PubMed ID: 8159650
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Hepatitis C virus-related hepatocellular carcinoma and liver cirrhosis.
    Pecic V, Stankovic-Djordjevic D, Nestorovic M, Radojkovic M, Marjanovic H, Ilic B, Milojkovic M.
    J BUON; 2011 Jan 10; 16(2):277-81. PubMed ID: 21766498
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.